Saranas, a Houston, TX-based medical device company, closed a $4m Series B financing round.
Backers were not disclosed.
Led by newly appointed President and CEO Zaffer Syed, Saranas provides a medical device featuring new technology for real-time detection of internal bleeding during cardiac procedures. The Early Bird device is a standard vascular access sheath embedded with sensors that can detect bleeding from a blood vessel accidentally ruptured during medical procedures – such as transcatheter aortic valve replacements (TAVRs), where the femoral artery is used to gain access to the heart. The technology was invented at the Texas Heart Institute.
The funding will be used to advance the company’s Early Bird™ Bleed Detection device through final product testing and FDA submission later this year.